Neuroscience
Dementia Praecox
100%
Treatment-Resistant Schizophrenia
54%
Antipsychotic
48%
Glutamic Acid
32%
Clozapine
31%
Transcranial Magnetic Stimulation
31%
Alzheimer's Disease
31%
Meta-Analysis
30%
Nuclear Magnetic Resonance Spectroscopy
28%
Major Depressive Disorder
22%
Positron Emission Tomography
21%
Eicosanoid Receptor
18%
Mild Cognitive Impairment
17%
Typical Antipsychotic
15%
Receptor Occupancy
14%
Anterior Cingulate Cortex
13%
Amyloid
13%
Dorsolateral Prefrontal Cortex
12%
Electroencephalography
12%
Glutamine
11%
Antidepressant
11%
Pervasive Developmental Disorder
11%
Treatment-Resistant Depression
11%
Depression
11%
Olanzapine
10%
Raclopride
10%
Neurophysiology
9%
Striatum
9%
Prefrontal Cortex
8%
Risperidone
8%
Negative Syndrome
8%
Magnetic Resonance Imaging
8%
Cognitive Disorders
7%
Ventral Striatum
7%
Basal Ganglia
7%
Dopaminergic
7%
Cingulate Cortex
7%
Fluorine-18
7%
Positive Syndrome
7%
Transcranial Magnetic Stimulation
6%
Evoked Potential
6%
Frontotemporal Dementia
6%
Gamma-Aminobutyric Acid
6%
Atypical Antipsychotic
6%
Frontal Lobe
5%
Cognitive Function
5%
Magnetic Resonance Imaging
5%
Benzodiazepine
5%
Mirtazapine
5%
Excitotoxicity
5%
Keyphrases
Treatment-resistant Schizophrenia
19%
Neurometabolites
19%
Proton Magnetic Resonance Spectroscopy
15%
Patients with Schizophrenia
14%
Meta-analysis
13%
Glutamatergic
12%
Clozapine
12%
Spectroscopy Studies
10%
Antipsychotics
9%
Schizophrenia
8%
Systematic Meta-analysis
8%
Retrospective Cohort Study
8%
Dopamine Depletion
7%
Healthy Individuals
7%
1H-MRS
6%
Older Patients
6%
Transcranial Magnetic Stimulation
6%
Treatment-resistant Depression
6%
Glutamine
5%
Treatment Effect
5%
Dopamine Release
5%
Anterior Cingulate Cortex
5%
γ-aminobutyric Acid
5%
Caudate
5%
Healthy Controls
5%
N-acetylaspartate
5%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
19%
Antipsychotic
19%
Treatment-Resistant Schizophrenia
14%
Clozapine
14%
Olanzapine
11%
Symptom
9%
Risperidone
9%
Naxagolide
9%
Antidepressant
8%
Disease
8%
Carbon 11
8%
Glutamic Acid
8%
Cohort Study
8%
Typical Antipsychotic
7%
Pharmacokinetics
6%
Treatment Resistant Depression
5%
Depression
5%
Dopamine Receptor
5%
Sodium Valproate
5%
Frontotemporal Dementia
5%
Alzheimer's Disease
5%